Back to Browse Journals » Nature and Science of Sleep » Volume 2

Neurocognitive performance and behavior before and after treatment for sleep-disordered breathing in children

Authors Mark J Kohler, Kurt Lushington, J Declan Kennedy

Published Date August 2010 Volume 2010:2 Pages 159—185

DOI http://dx.doi.org/10.2147/NSS.S6934

Published 16 August 2010

Mark J Kohler1, Kurt Lushington2, J Declan Kennedy1
1Children’s Research Centre, University of Adelaide, North Adelaide, Australia; 2School of Psychology, Social Work and Social Policy, University of South Australia, Adelaide, Australia
Abstract: Neurocognitive and behavioral problems are increasingly reported in children with sleep-disordered breathing (SDB). The impact of treatment for SDB on neurocognition and behavior is, therefore, an issue of increasing importance. To date, there has been little consideration given to the quality of studies when reviewing associated neurocognitive and behavioral problems in children with SDB, and furthermore, there has been little systematic review of treatment outcomes. The aim of this review was to provide an up-to-date and critical review of the current literature. Findings indicate a specific pattern of neurocognitive problems in children with SDB; however, the pattern of behavioral problems is less clear. Very few studies were found to provide a rigorous investigation of posttreatment neurocognitive and behavior outcomes. Despite this, relatively consistent improvements in global intelligence, attention, and visual spatial ability are shown; however, persistent deficits in other domains are also evident. For behavior, problems of hyperactivity, aggression or conduct problems, and somatic complaints improve following treatment. In contrast, symptoms of anxiety and social problems less consistently improve. These findings should aid in the development of more targeted investigations and well-designed studies exploring both the causative mechanisms and the treatment response for neurocognitive and behavior problems in children with SDB.
Keywords: adenotonsillectomy, neurocognition, sleep-disordered breathing, children, behavior

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Lysine-functionalized nanodiamonds: synthesis, physiochemical characterization, and nucleic acid binding studies

Kaur R, Chitanda JM, Michel D, Maley J, Borondics F, Yang P, Verrall RE, Badea I

International Journal of Nanomedicine 2012, 7:3851-3866

Published Date: 19 July 2012

Critical evaluation of the efficacy and tolerability of azilsartan

De Caterina AR, Harper AR, Cuculi F

Vascular Health and Risk Management 2012, 8:299-305

Published Date: 14 May 2012

Corrigendum

Chen ZQ, Liu Y, Zhao JH, Wang L, Feng NP

International Journal of Nanomedicine 2012, 7:1709-1710

Published Date: 30 March 2012

Preparation of poly(ethylene glycol)/polylactide hybrid fibrous scaffolds for bone tissue engineering

Ni P, Fu S, Fan M, Guo G, Shi S, Peng J, Luo F, Qian Z

International Journal of Nanomedicine 2011, 6:3065-3075

Published Date: 30 November 2011

Corrigendum

Escobar-Chávez JJ, Domínguez-Delgado CL, Rodríguez-Cruz IM

Drug Design, Development and Therapy 2011, 5:487-488

Published Date: 28 November 2011

Development, clinical utility, and place in therapy of posaconazole for prevention and treatment of invasive fungal infections

Emily Zoller, Connie Valente, Kyle Baker, et al

Drug Design, Development and Therapy 2010, 4:299-311

Published Date: 4 November 2010

Continuation treatment of major depressive disorder: is there a case for duloxetine?

Trevor R Norman, James S Olver

Drug Design, Development and Therapy 2010, 4:19-31

Published Date: 12 February 2010

Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses

Hideki Hasegawa, Takeshi Ichinohe, Akira Ainai, Shin-ichi Tamura, Takeshi Kurata

Therapeutics and Clinical Risk Management 2009, 5:125-132

Published Date: 9 March 2009

Pharmaco-management of inhalation injuries for burn survivors

Anthony C Bartley, Dale W Edgar, Fiona M Wood

Drug Design, Development and Therapy 2008, 2:9-16

Published Date: 8 January 2008